HPV42, a "Low-Risk" Type, and Digital Papillary Adenocarcinoma

Gabriel J Starrett1, John T Schiller1, Douglas R Lowy

  • 1Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Cancer Discovery
|January 9, 2023
PubMed
Abstract